Scientist Home Future Health Ltd

Scientist Home Future Health Ltd is a Nevada-based company that operates through its Hong Kong subsidiary, Scientist Home HK, in the retail trading of health supplements and topical creams. The business is organized around sourcing consumer health products and selling them through retail channels in Asia, with an investment-holding layer above the operating subsidiary.

−112,7 %

40,1 %

−113,6 %

0.90

0.74

— Scientist Home Future Health Ltd
%
Health supplements60% Oral wellness products sold for preventive care and general health support.
Topical creams40% Creams and ointments sold for localized relief and recovery support.

The company sells to health-conscious consumers seeking natural wellness products, preventive care, and relief from...

  • Health-conscious consumersprimary

    Buy supplements and topical products for general wellness and natural health support.

  • Preventive care customersprimary

    Purchase products aimed at maintaining health and addressing symptoms early.

  • Elderly and chronic-condition userssecondary

    Use topical creams and supplements for age-related discomfort and ongoing care.

  • Active lifestyle customerssecondary

    Buy products for muscle strain, soreness, and minor injury recovery.

The operating business is centered in Hong Kong, while the parent company is incorporated in Nevada and the holding...

  • •Operating subsidiary is based in Hong Kong
  • •Parent company is incorporated in Nevada
  • •Holding company is incorporated in the Marshall Islands
  • •Business focus is primarily in Asia

The company’s strategy is to build a consumer health and wellness retail business around supplements and topical...

01
Expand consumer wellness product salesmedium-term

Broader product adoption supports scale in a niche retail health business.

02
Strengthen distribution and pricing controlshort-term

Control over pricing and inventory helps protect product availability and margins.

03
Build presence in Asian consumer marketsmedium-term

The business is operationally concentrated in Hong Kong and broader Asia.

The company is exposed to small-scale operating risk, including dependence on a limited product set, inventory...

high

Inventory obsolescence

Supplements and creams can expire or become unmarketable if demand slows.

Scope
Inventory write-downs and gross margin volatility
Materiality
high
high

Related-party dependence

The company acquired a holding entity from its CEO and received advances from related parties.

Scope
Governance, financing, and conflict-of-interest risk
Materiality
high
medium

Supplier pricing and supply risk

The distributor agreement allows the supplier to revise prices and affects product availability.

Scope
Cost of sales and product continuity
Materiality
medium
medium

Concentrated operating footprint

Operations are primarily in Hong Kong and Asia, limiting geographic diversification.

Scope
Regional demand, regulatory, and logistics risk
Materiality
medium
Inventory obsolescence
Can trigger inventory write-downs and reduce gross profit
Expected credit loss
Affects asset valuation and bad debt expense
Revenue recognition
Affects timing of revenue and period comparability
Operating leases
Affects balance sheet leverage and occupancy expense

NATURAL HEALTH TRENDS CORP

NHTC · Wholesale-Miscellaneous Nondurable Goods

Zeo ScientifiX, Inc.

ZEOX · Biological Products, (No Diagnostic Substances)

NEXT-ChemX Corporation.

Miscellaneous Chemical Products

Nightingale Health Oyj

HEALTH.HE · Health Information Services

Singularity Future Technology Ltd.

SGLY · Arrangement of Transportation of Freight & Cargo

Intellia Therapeutics, Inc.

NTLA · In Vitro & In Vivo Diagnostic Substances

: 29.4.2026